Total Payments
$43,866
2024 Payments
$9,926
Companies
22
Transactions
58
Medicare Patients
1,304
Medicare Billing
$186,174
Payment Breakdown by Category
Consulting$30,423 (69.4%)
Other$9,230 (21.0%)
Travel$2,235 (5.1%)
Food & Beverage$1,978 (4.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $30,423 | 15 | 69.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $5,720 | 2 | 13.0% |
| Honoraria | $3,510 | 1 | 8.0% |
| Travel and Lodging | $2,235 | 11 | 5.1% |
| Food and Beverage | $1,978 | 29 | 4.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | $5,394 | 9 | $0 (2023) |
| Amgen Inc. | $5,311 | 6 | $0 (2017) |
| Merck Sharp & Dohme LLC | $5,005 | 4 | $0 (2024) |
| GlaxoSmithKline, LLC. | $4,550 | 2 | $0 (2022) |
| Deciphera Pharmaceuticals Inc. | $3,712 | 3 | $0 (2024) |
| Exelixis Inc. | $3,703 | 5 | $0 (2018) |
| Takeda Pharmaceuticals U.S.A., Inc. | $2,760 | 1 | $0 (2024) |
| Helsinn Therapeutics (U.S.), Inc. | $2,720 | 1 | $0 (2021) |
| Taiho Oncology, Inc. | $2,525 | 2 | $0 (2017) |
| Genentech USA, Inc. | $2,256 | 3 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $9,926 | 12 | Deciphera Pharmaceuticals Inc. ($3,712) |
| 2023 | $1,228 | 4 | Bayer Healthcare Pharmaceuticals Inc. ($1,028) |
| 2022 | $6,235 | 4 | GlaxoSmithKline, LLC. ($2,600) |
| 2021 | $6,220 | 3 | Helsinn Therapeutics (U.S.), Inc. ($2,720) |
| 2020 | $1,500 | 1 | Merck Sharp & Dohme Corporation ($1,500) |
| 2019 | $74.37 | 1 | E.R. Squibb & Sons, L.L.C. ($74.37) |
| 2018 | $8,530 | 19 | Bayer HealthCare Pharmaceuticals Inc. ($4,367) |
| 2017 | $10,152 | 14 | Amgen Inc. ($5,311) |
All Payment Transactions
58 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/01/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $62.42 | General |
| 09/25/2024 | Tempus AI, Inc | XT CDX (Device) | Food and Beverage | In-kind items and services | $122.33 | General |
| Category: NONE | ||||||
| 07/30/2024 | Boston Scientific Corporation | TheraSphere Y90 Glass Microspheres 10 GBq (Device) | Food and Beverage | In-kind items and services | $144.38 | General |
| Category: TheraSphere_PI | ||||||
| 07/10/2024 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $1,220.00 | General |
| 07/10/2024 | Merck Sharp & Dohme LLC | — | Travel and Lodging | Cash or cash equivalent | $150.00 | General |
| 05/28/2024 | Deciphera Pharmaceuticals Inc. | QINLOCK (Drug) | Honoraria | Cash or cash equivalent | $3,510.00 | General |
| Category: ONCOLOGY | ||||||
| 05/23/2024 | Takeda Pharmaceuticals U.S.A., Inc. | FRUZAQLA (Drug) | Consulting Fee | Cash or cash equivalent | $2,760.00 | General |
| Category: ONCOLOGY | ||||||
| 04/29/2024 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $1,675.00 | General |
| 04/18/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $63.47 | General |
| Category: Oncology | ||||||
| 02/28/2024 | Davol Inc. | — | Food and Beverage | In-kind items and services | $16.41 | General |
| 01/29/2024 | Deciphera Pharmaceuticals Inc. | QINLOCK (Drug) | Food and Beverage | Cash or cash equivalent | $114.42 | General |
| Category: ONCOLOGY | ||||||
| 01/29/2024 | Deciphera Pharmaceuticals Inc. | QINLOCK (Drug) | Food and Beverage | Cash or cash equivalent | $87.55 | General |
| Category: ONCOLOGY | ||||||
| 10/05/2023 | Bayer Healthcare Pharmaceuticals Inc. | Stivarga (Drug) | Consulting Fee | Cash or cash equivalent | $1,027.50 | General |
| Category: Oncology | ||||||
| 06/15/2023 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $66.33 | General |
| Category: Oncology | ||||||
| 05/30/2023 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $68.84 | General |
| Category: SURGERY | ||||||
| 05/18/2023 | Incyte Corporation | PEMAZYRE (Drug) | Food and Beverage | Cash or cash equivalent | $65.74 | General |
| Category: Hepatology (Liver, Pancreatic, Gall Bladder) | ||||||
| 11/18/2022 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $2,600.00 | General |
| 11/03/2022 | Seagen Inc. | TUKYSA (Drug) | Consulting Fee | Cash or cash equivalent | $1,375.00 | General |
| Category: Oncology | ||||||
| 10/05/2022 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $2,135.00 | General |
| 08/11/2022 | Rigel Pharmaceuticals, Inc. | Tavalisse (Drug) | Food and Beverage | In-kind items and services | $125.13 | General |
| Category: Hematology | ||||||
| 12/02/2021 | Helsinn Therapeutics (U.S.), Inc. | TRUSELTIQ (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,720.00 | General |
| Category: ONCOLOGY | ||||||
| 08/11/2021 | Ipsen Biopharmaceuticals, Inc | ONIVYDE (Drug) | Consulting Fee | Cash or cash equivalent | $1,550.00 | General |
| Category: Oncology | ||||||
| 08/06/2021 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $1,950.00 | General |
| 07/08/2020 | Merck Sharp & Dohme Corporation | — | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| 03/22/2019 | E.R. Squibb & Sons, L.L.C. | — | Travel and Lodging | Cash or cash equivalent | $74.37 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 281 | 431 | $116,015 | $35,826 |
| 2022 | 6 | 273 | 477 | $117,170 | $42,083 |
| 2021 | 8 | 401 | 675 | $130,555 | $58,945 |
| 2020 | 10 | 349 | 548 | $110,470 | $49,319 |
Total Patients
1,304
Total Services
2,131
Medicare Billing
$186,174
Procedure Codes
32
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 89 | 161 | $44,275 | $12,096 | 27.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 53 | 100 | $35,000 | $11,496 | 32.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 51 | 76 | $14,440 | $3,679 | 25.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 31 | 31 | $7,595 | $3,113 | 41.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 15 | 15 | $6,375 | $2,229 | 35.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 14 | 14 | $4,900 | $1,474 | 30.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 13 | 16 | $2,080 | $1,038 | 49.9% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 15 | 18 | $1,350 | $699.96 | 51.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 69 | 146 | $43,600 | $16,789 | 38.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 104 | 208 | $47,920 | $15,988 | 33.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 28 | 28 | $10,550 | $4,009 | 38.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 47 | 66 | $10,790 | $3,317 | 30.7% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 12 | 12 | $2,100 | $1,004 | 47.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 13 | 17 | $2,210 | $975.40 | 44.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 122 | 240 | $46,800 | $20,553 | 43.9% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 75 | 130 | $32,500 | $16,313 | 50.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 76 | 153 | $21,420 | $8,792 | 41.0% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 37 | 37 | $12,950 | $5,817 | 44.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 32 | 43 | $5,630 | $2,479 | 44.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 17 | 17 | $4,845 | $2,038 | 42.1% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 21 | 22 | $3,855 | $1,902 | 49.3% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 21 | 33 | $2,555 | $1,053 | 41.2% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 95 | 163 | $40,750 | $18,479 | 45.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 86 | 149 | $29,035 | $12,510 | 43.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 51 | 93 | $12,975 | $5,588 | 43.1% |
About Dr. Steven Cohen, M.D
Dr. Steven Cohen, M.D is a Specialist healthcare provider based in Abington, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1538136833.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Steven Cohen, M.D has received a total of $43,866 in payments from pharmaceutical and medical device companies, with $9,926 received in 2024. These payments were reported across 58 transactions from 22 companies. The most common payment nature is "Consulting Fee" ($30,423).
As a Medicare-enrolled provider, Cohen has provided services to 1,304 Medicare beneficiaries, totaling 2,131 services with total Medicare billing of $186,174. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Other Specialties Medical Oncology
- Location Abington, PA
- Active Since 03/06/2006
- Last Updated 09/06/2016
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1538136833
Products in Payments
- Vectibix (Biological) $5,311
- QINLOCK (Drug) $3,712
- Cabometyx (Drug) $3,703
- Nexavar (Drug) $3,467
- FRUZAQLA (Drug) $2,760
- TRUSELTIQ (Drug) $2,720
- Lonsurf (Drug) $2,525
- Avastin (Biological) $2,256
- Stivarga (Drug) $1,928
- ONIVYDE (Drug) $1,550
- TUKYSA (Drug) $1,375
- FOUNDATIONACT (Device) $400.58
- TheraSphere Y90 Glass Microspheres 10 GBq (Device) $144.38
- Tavalisse (Drug) $125.13
- XT CDX (Device) $122.33
- FOUNDATIONONE (Device) $95.74
- Da Vinci Surgical System (Device) $68.84
- Lenvima (Drug) $66.33
- PEMAZYRE (Drug) $65.74
- OPDIVO (Biological) $63.47
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Abington
Philip Sasso, M.d, M.D
Specialist — Payments: $32,141
Specialist $32,141
Jeremy Jaffe, M.d, M.D
Specialist — Payments: $24,784
Specialist $24,784
Lisette Volckmar, M.d, M.D
Specialist — Payments: $274.46
Specialist $274.46
Luis Mercader, M.d, M.D
Specialist — Payments: $273.90
Specialist $273.90
Robert Atkins, M.d, M.D
Specialist — Payments: $174.94
Specialist $174.94
Peter Vacca, M.d, M.D
Specialist — Payments: $115.46
Specialist $115.46